Spectranetics Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt(R) Scoring Balloon Enabling Entry Into New Markets
June 24, 2015 16:01 ET
|
The Spectranetics Corporation
Unlocks niche in endovascular care with $150M market opportunity;
Enables physicians to deliver precision, power, safety for hemodialysis fistula or graft
COLORADO SPRINGS, Colo., June 24, 2015...
EXCITE ISR Landmark Study Proves Durability at 12-Months, Findings Validate Safety and Superiority of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at NCVH 2015
May 27, 2015 16:10 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., May 27, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that 12-month data from the EXCITE ISR clinical trial were presented by Craig...
Spectranetics to Participate in Upcoming Investor Conferences
April 30, 2015 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., April 30, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in two upcoming investor...
Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
April 23, 2015 16:03 ET
|
The Spectranetics Corporation
Expands Stellarex™ Program to Below the Knee Market
Updates 2015 Outlook
COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today...
Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of Below the Knee (BTK) Peripheral Vascular Disease
April 23, 2015 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced it is accelerating investments in the Stellarex drug-coated balloon angioplasty...
Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23
April 13, 2015 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., April 13, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2015 first quarter financial results after market...
Spectranetics Announces Chief Financial Officer Transition
March 18, 2015 17:45 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., March 18, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) reported today that Guy Childs, Chief Financial Officer, has announced his plan to transition...
Spectranetics Appoints Todd C. Schermerhorn as Director
March 12, 2015 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., March 12, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its Board of Directors has appointed Todd C. Schermerhorn to the Board,...
Spectranetics Achieves Fourth Quarter 2014 Revenue of $63.0 Million
February 19, 2015 16:01 ET
|
The Spectranetics Corporation
Stellarex DCB Acquisition Closed and Stellarex Launched in Europe
Updates 2015 Outlook
COLORADO SPRINGS, Colo., Feb. 19, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC)...
Spectranetics to Hold 2014 Fourth Quarter Financial Results Conference Call on February 19
February 05, 2015 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Feb. 5, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2014 fourth quarter financial results after market...